symmetric dimethylarginine has been researched along with nitroglycerin in 1 studies
| Studies (symmetric dimethylarginine) | Trials (symmetric dimethylarginine) | Recent Studies (post-2010) (symmetric dimethylarginine) | Studies (nitroglycerin) | Trials (nitroglycerin) | Recent Studies (post-2010) (nitroglycerin) |
|---|---|---|---|---|---|
| 428 | 27 | 314 | 12,659 | 2,240 | 1,398 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, WP; Heresztyn, T; Horowitz, JD; Liberts, EA; Marber, MS; Norman, RJ; Rajendran, S; Saha, M; Willoughby, SR | 1 |
1 other study(ies) available for symmetric dimethylarginine and nitroglycerin
| Article | Year |
|---|---|
Polycystic ovary syndrome is associated with severe platelet and endothelial dysfunction in both obese and lean subjects.
Topics: Adenosine Diphosphate; Adult; Albuterol; Arginine; Body Composition; C-Reactive Protein; Cohort Studies; Endothelial Cells; Endothelium, Vascular; Female; Humans; Inflammation Mediators; Malondialdehyde; Nitric Oxide; Nitric Oxide Donors; Nitroglycerin; Nitroprusside; Obesity; Oxidative Stress; Platelet Aggregation; Platelet Function Tests; Polycystic Ovary Syndrome; Stem Cells; Time Factors; Vasodilator Agents | 2009 |